Skip to main content

Jill Pulley Archives

VUMC to test whether Alzheimer’s drug can ease lupus symptoms

Oct. 6, 2022—Vanderbilt University Medical Center is partnering with Evergreen Therapeutics Inc. to test whether an Alzheimer’s drug, memantine, can improve cognitive symptoms associated with systemic lupus.

Read more


VUMC and Roivant Social Ventures announce collaboration to develop therapies for underserved populations

Jul. 6, 2022—Vanderbilt University Medical Center and Roivant Social Ventures (RSV) this week announced an intention to collaborate in developing therapies for traditionally underserved populations and diseases.

Read more


Computer-based study reveals impact of race on health

Oct. 8, 2020—A computer-based method developed at Vanderbilt University Medical Center that scans electronic medical records (EMRs) for genetic contributors to disease has been used for the first time to reveal the impact of race on health.

Read more


VUMC’s program to repurpose drugs lands international acclaim

Jul. 23, 2020—Vanderbilt University Medical Center is attracting international attention for its proposal to repurpose existing drugs for new uses in ways that can dramatically improve access to medicines by billions of people throughout the world.

Read more


VUMC team fills COVID information gaps for web users

Jul. 10, 2020—For the world’s web users, Vanderbilt University Medical Center is working with Google to address COVID-19 information gaps.

Read more


VUMC drug repurposing initiative gaining momentum

Apr. 19, 2018—Drug repurposing involves establishing an additional approved indication for a drug already at market.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more